최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.33 no.1, 2023년, pp.64 - 72
전세진 (안동대학교 생명공학부 생명백신공학전공)
Despite several advances in identification of cardiac transcription factors, there are still needs to find new bioactive molecules that promote cardiomyogenesis from stem cells to highly efficient myocardial differentiation. We analyzed Illumina expression microarray data of mouse embryonic stem cel...
Behfar, A., Zingman, L. V., Hodgson, D. M., Rauzier, J. M., Kane, G. C., Terzic, A. and Puceat, M. 2002. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J. 16, 1558-1566.
Beqqali, A., Kloots, J., Ward-van, Oostwaard D., Mummery, C. and Passier, R. 2006. Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes. Stem Cells 24, 1956-1967.
Boheler, K. R., Czyz, J., Tweedie, D., Yang, H. T., Anisimov, S.V. and Wobus A. M. 2002. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ. Res. 91, 189-201.
Brochmann, E. J., Behnam, K. and Murray, S. S. 2009. Bone morphogenetic protein-2 activity is regulated by secreted phosphoprotein-24 kd, an extracellular pseudoreceptor, the gene for which maps to a region of the human genome important for bone quality. Metabolism 58, 644-650.
Brochmann, E. J., Simon, R. J., Jawien, J., Behnam, K., Sintuu, C., Wang, J. C. and Murray, S. S. 2010. Carboxy terminus of secreted phosphoprotein-24 kDa (spp24) is essential for full inhibition of BMP-2 activity. J. Orthop. Res. 28, 1200-1207.
Dib, N., Michler, R. E., Pagani, F. D., Wright, S., Kereiakes, D. J., Lengerich, R., Binkley, P., Buchele, D., Anand, I., Swingen, C., Di, Carli, M. F., Thomas, J. D., Jaber, W. A., Opie, S. R., Campbell, A., McCarthy, P., Yeager, M., Dilsizian, V., Griffith, B. P., Korn, R., Kreuger, S. K., Ghazoul, M., MacLellan, W. R., Fonarow, G., Eisen, H. J., Dinsmore, J. and Diethrich, E. 2005. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 112, 1748-1755.
Ding, S. and Schultz, P. G. 2004. A role for chemistry in stem cell biology. Nat. Biotechnol. 22, 833-840.
Doss, M. X., Koehler, C. I., Gissel, C., Hescheler, J. and Sachinidis, A. 2004. Embryonic stem cells: a promising tool for cell replacement therapy. J. Cell. Mol. Med. 8, 465-473.
Gonzalez, A., Rota, M., Nurzynska, D., Misao, Y., Tillmanns, J., Ojaimi, C., Padin-Iruegas, M. E., Muller, P., Esposito, G., Bearzi, C., Vitale, S., Dawn, B., Sanganalmath, S. K., Baker, M., Hintze, T. H., Bolli, R., Urbanek, K., Hosoda, T., Anversa, P., Kajstura, J. and Leri, A. 2008. Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ. Res. 102, 597-606.
Jacob, G. S., Daniel, R. B., Julie, A. B., Travis, H., Bingruo, W., Thomas, C. T., Stephen, E. H., Bin, Z., Yuji, M. and Yukiko, S. 2017. BMP2 expression in the endocardial lineage is required for AV endocardial cushion maturation and remodeling. Dev. Biol. 430, 113-128.
Jamali, M., Rogerson, P. J., Wilton, S. and Skerjanc, I. S. 2001. Nkx2-5 activity is essential for cardiomyogenesis. J. Biol. Chem. 276, 42252-42258.
Juan, F. S., Hristina, O. and Jelena, K. 2021. BMP2 downregulates urokinase-type plasminogen activator via p38 MAPK: Implications in C2C12 cells myogenic differentiation. Acta Histochem. 123, 151774.
Karamboulas, C., Dakubo, G. D., Liu, J., De, Repentigny Y., Yutzey, K., Wallace, V. A., Kothary, R. and Skerjanc, I. S. 2006. Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis. J. Cell Sci. 119, 4315-4321.
Kawai, T., Takahashi, T., Esaki, M., Ushikoshi, H., Nagano, S., Fujiwara, H. and Kosai, K. 2004. Efficient cardiomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenetic protein 2. Circ. J. 68, 691-702.
Keller, G. M. 1995. In vitro differentiation of embryonic stem cells. Curr. Opin. Cell Biol. 7, 862-869.
Menasche, P., Alfieri, O., Janssens, S., McKenna, W., Reichenspurner, H., Trinquart, L., Vilquin, J. T., Marolleau, J. P., Seymour, B., Larghero, J., Lake, S., Chatellier, G., Solomon, S., Desnos, M. and Hagege, A. A. 2008. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117, 1189-1200.
Mike, A. K., Koenig, X., Koley, M., Heher, P., Wahl, G., Rubi, L., Schnurch, M., Mihovilovic, M. D., Weitzer, G. and Hilber, K. 2014. Small molecule cardiogenol C upregulates cardiac markers and induces cardiac functional properties in lineage-committed progenitor cells. Cell Physiol. Biochem. 33, 205-221.
Murray, E. J., Murray, S. S., Simon, R. and Behnam, K. 2007. Recombinant expression, isolation, and proteolysis of extracellular matrix-secreted phosphoprotein-24 kDa. Connect Tissue Res. 48, 292-299.
Murray, S. S., Wang, J. C., Duarte, M. E., Zhao, K. W., Tian, H., Francis, T. and Brochmann Murray, E. J. 2015. The bone matrix protein secreted phosphoprotein 24 kD (Spp24): bone metabolism regulator and starting material for biotherapeutic materials. Histol. Histopathol. 30, 531-537.
Oh, H., Bradfute, S. B., Gallardo, T. D., Nakamura, T., Gaussin, V., Mishina, Y., Pocius, J., Michael, L. H., Behringer, R. R., Garry, D. J., Entman, M. L. and Schneider, M. D. 2003. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. USA. 100, 12313-12318.
Oh, S. W., Kim, B., Jeon, S., Go, D. M., Kim, M. K., Baek, K., Oh, G. T. and Kim, D. Y. 2013. Identification and characterization of CW108F, a novel β-carboline compound that promotes cardiomyogenesis of stem cells. Life Sci. 93, 409-15.
Ooi, O. C., Al Habib, H. F., Almsherqi, Z. A. and El Oakley, R. M. 2006. Stem cell transplantation: potential impact on heart failure. Cell Tissue Bank 7, 307-317.
Sintuu, C., Murray, S. S., Behnam, K., Simon, R., Jawien, J., Silva, J. D., Duarte, M. E. and Brochmann, E. J. 2008. Full-length bovine spp24 [spp24 (24-203)] inhibits BMP-2 induced bone formation. J. Orthop. Res. 26, 753-758.
Turner, M. E., White, C. A., Taylor, S. M., Neville, K., Rees-Milton, K., Hopman, W. M., Adams, M. A., Anastas siades, T. and Holden, R. M. 2021. Secreted phosphoprotein 24 is a biomarker of mineral metabolism. Calcif Tissue Int. 108, 354-363.
Wu, X., Ding, S., Ding, Q., Gray, N. S. and Schultz, P. G. 2004. Small molecules that induce cardiomyogenesis in embryonic stem cells. J. Am. Chem. Soc. 126, 1590-1591.
Yamamoto, N., Akiyama, S., Katagiri, T., Namiki, M., Kurokawa, T. and Suda, T. 1997. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem. Biophys. Res. Commun. 238, 574-580.
Yuasa, S., Itabashi, Y., Koshimizu, U., Tanaka, T., Sugimura, K., Kinoshita, M., Hattori, F., Fukami, S., Shimazaki, T., Ogawa, S., Okano, H. and Fukuda, K. 2005. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat. Biotechnol. 23, 607-611.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.